ERYTECH PHARMA (sponsor ADRs) will present the figures for the most recent quarter, which ended on December 31, 2020, at the financial conference that is expected to take place on March 8th, 2021.
2 analysts estimate on average that ERYTECH PHARMA (spons ADRs) will report a loss per share of -1.084 USD for the most recent quarter. In the previous year, the company had generated an EPS of USD 1.206 per share.
The estimates of 2 analysts assume the average turnover for the past quarter of USD 2.3 million – that corresponds to an increase of 49.36 percent compared to the same quarter of the previous year, in which USD 1.6 million were on the books.
Looking at the entire past fiscal year, 3 analysts expect an average loss of -4.425 USD per share. In the previous fiscal year a loss of USD -3.896 per share was reported. 4 analysts estimate the turnover at an average of 5.7 million USD, compared to 5.9 million USD in the corresponding period before.
[ source link ]
estimates ERYTECH PHARMA sponsor ADRs takes stock quarter